Archives

CDPQ welcomes the renewal of CAE’s Board

Cdpq

CDPQ welcomes the announcement, by CAE’s Board of Directors, of the appointment of four new members, including the appointment of Calin Rovinescu, a seasoned leader in the aerospace industry, as Chairman. These changes reflect CAE’s commitment to renewing its corporate governance, in particular by taking into account the opinions of certain shareholders, including CDPQ, its largest institutional investor with a 9.7% stake in the company.

“Our position as a major shareholder prompted us to play a proactive and constructive role in this renewal process by leveraging our network and influence. This mobilization and the end result perfectly illustrate our dual mandate: while we aim to achieve optimal returns, we do not hesitate to get involved when necessary to support champions of the Québec economy, like CAE,” said Kim Thomassin, Executive Vice-President and Head of Québec at CDPQ. “CAE and its Board of Directors will be able to count on a renowned and seasoned Chairman whose career has been characterized by major achievements in business as well as in the aerospace industry, in Québec, Canada and internationally.”

CDPQ is also pleased with the three other appointments that have been announced, including those of Louis Têtu, whom it has designated as a director, Katherine A. Lehman and Peter Lee who join the group of experienced directors already in place to move the company forward. More specifically, CDPQ highlights the mobilization of influential individuals in the Québec business community to play active roles in the governance of this global leader in the aerospace industry.

These changes will become effective on February 14, 2025.

About CDPQ

At CDPQ, we invest constructively to generate sustainable returns over the long term. As a global investment group managing funds for public pension and insurance plans, we work alongside our partners to build enterprises that drive performance and progress. We are active in the major financial markets, private equity, infrastructure, real estate and private debt. As at June 30, 2024, CDPQ’s net assets totalled CAD 452 billion. For more information, visit cdpq.com, consult our LinkedIn or Instagram pages, or follow us on X.

CDPQ is a registered trademark owned by Caisse de dépôt et placement du Québec and licensed for use by its subsidiaries.

– 30 –

For more information

Categories: People

EQT portfolio company HBX Group, a leading independent B2B travel technology marketplace, goes public on the Spanish Stock Exchange

eqt

EQT is pleased to announce that EQT VII (“EQT Private Equity”) portfolio company HBX Group International plc (“HBX Group” or the “Company”) has successfully completed its initial public offering (“IPO”) and began trading today on the Spanish stock exchange. At an IPO price of EUR 11.50 per share, the listing follows the initial offering of the Company’s shares, comprising an offering of EUR 748 million, including a secondary offering of existing ordinary shares of the Company. Together with the additional overallotment option of up to 15% of the size of the base offering, the total offer size is up to EUR 860 million. The share price closed at EUR 11.00 per share at the end of the first trading day, implying a market capitalization of EUR 2.7 billion.

HBX Group is a leading independent B2B travel technology marketplace, connecting travel product suppliers (including hotels, travel experiences, transfers and car rentals) and travel distributors, totaling more than 635,000 direct connections in the travel ecosystem. Its best-in-class cloud-native and scalable technology platform allows the Group to process up to 6.2 billion searches per day, which provide unique insights for business partners and predict travel trends. HBX Group is also leveraging AI and developing a wide range of TravelTech solutions, including bespoke Fintech and Insurance solutions for the travel industry. HBX Group is present in 170 countries and employs more than 3,600 people around the globe.

EQT Private Equity’s association with HBX Group began with the merger of its previous portfolio company GTA and HBX Group in 2017, which resulted in EQT Private Equity acquiring a minority stake in HBX Group. Previously, GTA was one of the three core businesses of Kuoni Group, which EQT Private Equity acquired in May 2016. The other two core businesses, GTS and VFS Global, were divested by EQT in 2017 and 2022 respectively.

The IPO marks a significant milestone in HBX Group’s journey, providing it with a diversified shareholder base and access to public capital markets to support the Company’s future growth. Dominik Stein, Partner and Head of EQT Growth Advisory Team, commented: “EQT extends its congratulations to HBX Group’s management team and fellow shareholders, including Cinven and the Canada Pension Plan Investment Board, on reaching this milestone.”

Contact

EQT Press Office, press@eqtpartners.com

About EQT

EQT is a purpose-driven global investment organization with EUR 269 billion in total assets under management (EUR 136 billion in fee-generating assets under management), within two business segments – Private Capital and Real Assets. EQT owns portfolio companies and assets in Europe, Asia Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership.

More info: www.eqtgroup.com
Follow EQT on LinkedIn, X, YouTube and Instagram

About HBX Group

HBX Group is a leading global B2B TravelTech company that owns and operates Hotelbeds, Bedsonline and Roiback, among other brands. The company offers a network of interconnected travel tech products and services to partners such as Online Marketplaces, Tour Operators, Travel Advisers, Airlines and Loyalty Programmes, destinations and travel suppliers. HBX Group’s vision is to simplify the complex and fragmented travel industry through a combination of cloud-based technology solutions, curated data, and an extensive portfolio of products designed to maximise revenue. HBX Group is present in 170 countries, employs more than 3,600 people around the globe and is committed to making travel a force for good, creating a positive social and environmental impact. More info: www.hbxgroup.com

This press release does not constitute an offering circular or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017 and nothing herein shall be construed as an offering of securities. No one should purchase any securities in the Company except on the basis of information in the prospectus published by the Company in connection with the offering and admission of such securities to trading on the Spanish stock exchanges. Copies of the prospectus are available at the Company’s registered office and, subject to certain exceptions, through the website of the Company.

This press release is not an offer to sell or a solicitation of any offer to buy any securities issued by the Company in any jurisdiction where such offer or sale would be unlawful and this announcement and the information contained herein are not for distribution or release, directly or indirectly, in or into such jurisdictions.

Exclusive News and Insights

Categories: News

Tags:

Inflexion appoints partner to lead new North America office

Inflexion

Inflexion, a leading European mid-market private equity firm, is delighted to announce the appointment of Ben Meyer as a Partner and Head of North America. Ben will lead a new office for Inflexion in New York, building a dedicated team which will focus primarily on supporting Inflexion portfolio companies and accelerating their North American market entry through ambitious acquisitions.

Ben brings close to 25 years of relevant experience to Inflexion. He joins the firm from Hg where he spent five years helping the firm open and build its US presence, establishing its US brand, growing the US team to over 50 professionals and helping the firm invest in over 10 US businesses. Prior to Hg, Ben was a senior member of Temasek’s US team, where he helped build and lead Temasek’s direct US technology & software investment efforts.  Ben started his career at UBS Investment Bank in New York.

The New York team will support Inflexion’s portfolio companies to execute their US growth initiatives, with a specific focus on strategic and transformational acquisitions. Driving US expansion is a key part of Inflexion’s portfolio strategy: acquisitive growth has been a key value acceleration driver for Inflexion throughout its history, with over 540 bolt-ons completed in the last 25 years, and Inflexion portfolio companies have almost tripled their US revenues during the investment period.

We are delighted to welcome Ben to Inflexion to spearhead our expansion in North America. Hiring Ben underscores our commitment to accelerating the international growth of our portfolio companies, and by building a presence in the US, we are better positioned to support them on their growth ambitions and acquisition goals in the largest market in the world.

Flor Kassai, Managing Partner, Inflexion

The North American market presents a strategic expansion opportunity for Inflexion’s portfolio. I’m excited to join Inflexion to lead the North American effort, working work in concert with the global team and helping help Inflexion’s portfolio access the massive North American market.

Ben Meyer, Partner & Head of North America, Inflexion

Contact

Sarah Gestetner

Partner

T. +44 (0)20 7487 9820

E. sarah.gestetner@inflexion.com

Categories: People

Platinum Equity Completes Acquisition of Héroux-Devtek

Platinum

LOS ANGELES (February 12, 2025) – Platinum Equity announced today that the acquisition of Héroux-Devtek Inc. (TSX: HRX), a leading international manufacturer of aerospace products and the world’s third-largest landing gear manufacturer, has been completed.

 

“We have been investing in Canada for a long time and know the market dynamics and leading sectors very well. We believe there are a lot of opportunities to create value in partnership with Canadian businesses that can benefit from our approach. ”

Louis Samson, Co-President, Platinum Equity

“We have tremendous respect for Héroux-Devtek and are excited to work with Gilles, Martin, Stéphane, and the rest of the company’s talented team,” said Louis Samson, Co-President of Platinum Equity. “We are particularly inspired by the company’s entrepreneurial spirit and its ‘can do’ culture.”

Samson reaffirmed a commitment to maintaining Héroux-Devtek’s headquarters in Longueuil and investing in its R&D center in Saint-Hubert. He also said he was grateful and excited for long-term local investors Caisse de dépôt et placement du Québec (CDPQ) and Fonds de solidarité FTQ (FTQ) to have invested in the debt financing for the transaction.

“Montréal has a rich heritage in aerospace and Héroux-Devtek will remain a cornerstone of the regional economy,” said Samson. “We are also proud to have meaningful investments from CDPQ and FTQ in the company. They will be important strategic partners in the company’s future.”

“We are positive on the sector and very excited to be part of Héroux’s new chapter as a private company,” said Platinum Equity Managing Director Delara Zarrabi. “We like many of the company’s attributes, including its diversified portfolio of long-life programs, attractive mix of defense and commercial aerospace exposure, and meaningful earnings from aftermarket and proprietary designs.”

Zarrabi said Platinum Equity will look to grow Héroux organically and through prospective acquisitions.

“We have already developed and will continue to expand a pipeline of M&A opportunities for Héroux to pursue,” she said. “We will deploy the full range of our financial and operational toolkit to support the company’s continued success.”

Samson said Platinum Equity continues seeking opportunities to expand its portfolio of Canadian investments.

“We have been investing in Canada for a long time and know the market dynamics and leading sectors very well,” explained Samson, who grew up in Québec City. “We believe there are a lot of opportunities to create value in partnership with Canadian businesses that can benefit from our approach.”

Platinum Equity’s current portfolio also includes Husky Technologies, a provider of injection molding equipment and services headquartered in Bolton, Ontario. Platinum Equity recently sold Toronto-based Livingston International, an international trade services firm specializing in customs brokerage, freight forwarding and trade consulting, to Purolator, Inc.

Stikeman Elliott LLP and Latham & Watkins LLP served as legal advisors to Platinum Equity on the acquisition. BMO Capital Markets served as financial advisor to Platinum Equity and as the lead arranger for the financing.

About Platinum Equity

Founded in 1995 by Tom Gores, Platinum Equity is a global investment firm with more than $48 billion of assets under management and a portfolio of more than 50 operating companies that serve customers around the world. Platinum Equity specializes in mergers, acquisitions and operations – a trademarked strategy it calls M&A&O® – acquiring and operating companies in a broad range of business markets, including manufacturing, distribution, transportation and logistics, equipment rental, metals services, media and entertainment, technology, telecommunications and other industries. Over the past 29 years Platinum Equity has completed more than 450 acquisitions.

Categories: News

Eurazeo participates in GERMITEC’S EUR 29 million series B fundraising

Eurazeo

The Nov Santé Actions Non Cotées Fund, managed by Eurazeo1, dedicated to the development of the healthcare sector in Europe and which was launched at the initiative of France Assureurs and the Caisse des Dépôts, is announcing the finalization of its third Growth Equity investment in Germitec. Nov Santé Actions Non Cotées is acting as lead investor in this €29 million Series B fundraising alongside historic shareholders including Kurma Partners (Eurazeo’s Health Venture subsidiary), Financière Arbevel, Turenne Capital and the founding family.

Germitec: an innovative French MedTech specializing in High-Level Disinfection solutions for ultrasound probes

Germitec, whose headquarters are based in Bordeaux, is a leader in the field of ultrasound probe disinfection. Using patented technology, the company designs automatic UV-C High Level Disinfection solutions for external, long and short endocavitary and transesophageal ultrasound probes as well as ENT endoscopes without working channel which are all notably used in gynecology and IVF treatments, cardiology, urology and ENT. Using cycles ranging from 90 seconds to approximately 3 minutes, these chemical-free and single-button automatic devices considerably reduce the risk of cross-contamination. Moreover, the intuitive workflow interface enables data storage, visualization and downloading to guarantee complete traceability of the disinfection process.

Its environmentally friendly technology provides an alternative to existing offers on the market (automated or manual chemical solutions such as wipes or chemical baths) whilst meeting the demands of health professionals.

The demand in the global disinfection market is booming, driven by growing needs in the prevention of healthcare-associated infections (in 2023, 72,000 people in the USA and 4,000 in France died because of an infection caught in a medical environment) and the growth dynamic in the use of ultrasound as a reference-tool in medical imagery. By offering solutions adapted to the needs of healthcare professionals, Germitec is positioning itself as a major player in a key public health sector.

With a presence in over 40 countries, Germitec already benefits from international recognition and is today aiming to establish itself in new markets such as the United States, where the company recently obtained the FDA De Novo certification2 for its flagship Chronos3 product. To meet its goals, the company is raising €29 million with the support of Nov Santé Actions Non Cotées acting as lead investor alongside existing investors who are again participating in this second round.

A symbol of the Eurazeo group’s healthcare expertise

This co-investment between Nov Santé Actions Non Cotées and Kurma Partners, its Health Venture subsidiary, Eurazeo reaffirms its commitment to build its leadership in the strategic healthcare sector. Following on from PanTera in September 2024, this new joint participation illustrates the complementarity of skills within the Group which aims to support innovation and the emergence of industrial European leaders in the healthcare sector.

Following on from Kinvent in December 2023 and PanTera in September 2024, Germitec is the third Growth Equity investment by Nov Santé Actions Non Cotées.

Vincent Gardès, CEO of Germitec, declared:

“The Nov Santé and Kurma Partners teams’ expertise is a major asset that will support Germitec in our new development phase. With the obtention of the FDA accreditation, we have accomplished a decisive move that provides us with an exceptional perspective in the United States where there is a market opportunity of 60,000 units. We are confident in our capacity to capture this market thanks to the quality and distinction of our products, as well as the commitment and expertise of our teams.”

Arnaud Vincent, Managing Director – Healthcare at Eurazeo, added:

“We are very proud that Germitec and its historic shareholders have chosen Eurazeo as lead investor. We have been convinced by the company’s expertise, its innovative position, as demonstrated by its FDA accreditation, and the quality of its management. We are delighted to participate in this new phase for Germitec: the roll-out of its solution in the United States. By supporting Germitec, we are contributing to the advancement of healthcare solutions that respond to major challenges in public healthcare with the prevention of nosocomial infections and are supporting French healthcare sovereignty with products that are fabricated on home soil.”

**********************
1 As part of the Eurazeo Global Investor company.
2 The FDA’s De Novo classification process creates, when the technology is not matched by any other, a new classification validating marketing and distribution of medical devices in the US.
3 September 5th, 2024, Germitec’s press release: Germitec’s Chronos® Achieves First-Ever FDA De Novo: A Breakthrough in Infection Prevention.

Categories: News

Tags:

Candid Health Raises $52.5 Million Series C to Enhance GenAI Features, Expand Revenue Cycle Automation Platform to More Providers

Oak HC FT

Candid Health, the autonomous revenue cycle automation platform for healthcare providers, today announced it has raised $52.5 million in Series C funding led by Oak HC/FT with participation from existing investors. This brings the company’s total amount raised to $99.5 million.

Providers spend more than $100 billion annually on revenue cycle management, yet today’s billing requirements outpace available tooling. According to research by McKinsey, streamlining the claims submission process could save up to 18% of administrative costs as submission error rates have continued to increase.

Candid’s platform addresses the root cause of RCM inefficiency through modern data engineering and automation. Unlike traditional RCM companies which aim to make manual clean up work more efficient, Candid improves touchless claim rate, which is the percentage of claims submitted, processed and adjudicated correctly the first time with no manual intervention. Candid’s platform significantly increases the number of claims submitted correctly the first time, thereby eliminating avoidable, manual work for billing teams.

With touchless claim rates and payor net collection rates greater than 95%, the Candid platform drives industry-leading results. Candid clients experience increased overall net collections and faster reimbursement times while reducing costs with a scalable technical infrastructure.

“At Candid, we are reimagining the level of automation that an RCM platform can drive, and with AI, we are positioned to further improve billing performance,” said Nick Perry, CEO & Co-Founder of Candid Health. “We are excited to continue to grow and scale alongside our customers, fully supporting them along their journey, while forging relationships with more providers.”

The company grew revenue nearly 250% YoY in 2024. With this Series C investment, Candid will look to expand its customer relationships with multi-site provider groups nationally.

“The Candid leadership team has an exceptional blend of technical and product expertise, and they have rigorously built a platform with their customers’ needs top of mind,” said Billy Deitch, Partner at Oak HC/FT. “Our team has been investing in the RCM space for more than 25 years, and we think Candid is uniquely positioned to make a meaningful impact in this market. We are humbled at the opportunity to partner with the company as it expands its footprint with healthcare providers nationwide.”

About Candid Health 

Candid was founded by Nick Perry (CEO), Doug Proctor (COO) and Adam Reis. The team is on a mission to simplify medical billing, allowing providers to focus on delivering quality care. Trusted by more than 200 leading healthcare organizations, Candid’s revenue cycle platform leverages advanced automation to decrease the cost to collect and increase net collection rates. The company is backed by Oak HC/FT, 8VC, First Round Capital, Y Combinator, and Boxgroup. Learn more at https://www.joincandidhealth.com/company.

About Oak HC/FT 

Oak HC/FT is a venture and growth equity firm specializing in investments in fintech and healthcare. Using partnership as a foundation, Oak HC/FT guides companies and founders at every stage, from seed to growth, to create businesses that make a measurable and lasting impact. Founded in 2014, Oak HC/FT has invested in over 85 portfolio companies and has over $5.3 billion in assets under management. Oak HC/FT is headquartered in Stamford, CT, with an office in San Francisco, CA. Follow Oak HC/FT on LinkedIn and X and learn more at https://www.oakhcft.com/.

Categories: News

Tags:

Torrent Group to acquire majority stake in Gujarat Titans

CVC Capital Partners
  • Acquisition to mark Torrent Group’s foray into India’s rapidly growing sports sector
  • CVC Funds will continue to own a substantial minority stake in Gujarat Titans

Torrent Group (“Torrent”), a diversified conglomerate having interests in Healthcare and Energy sectors, through its holding company Torrent Investments Private Limited (TIPL), has entered into a definitive agreement to acquire majority stake of 67% in the renowned Indian Premier League (IPL) franchise, Gujarat Titans (Irelia Sports India Private Limited) from Irelia Company Pte Ltd (“Irelia”) – currently fully owned by funds managed or advised by CVC. The transaction is subject to customary closing conditions and approvals (including from BCCI).

As part of the deal, Irelia will retain a substantial minority stake of 33% in the franchise. This strategic partnership between one of India’s leading Business Groups and a globally renowned Private Equity firm, is the first of its kind in India’s sports sector and will unlock exciting opportunities for growth and collaboration.

Speaking on the occasion, Jinal Mehta, Director, Torrent Group, said, “It is a matter of great pride for us to welcome Gujarat Titans and millions of its passionate fans into the Torrent Group. As Sports continues to gain prominence in India, Torrent sees great potential in this rapidly growing sector. With the acquisition of a majority stake in the Gujarat Titans, we are excited to have the opportunity to elevate our fan experience and unlock new growth avenues in the years to come. We are committed to nurturing the Gujarat Titans team and creating a lasting legacy for everyone involved – our fanbase, the players and our employees. With a proven track-record of delivering high quality products and services across multiple sectors, Torrent is well-positioned to set new standards of excellence in the Sports industry through the acquisition of Gujarat Titans.”

We are excited to announce this deal, which marks the beginning of a new chapter in India’s most popular sporting event and our team Gujarat Titans

Siddharth PatelManaging Partner at CVC

Siddharth Patel, Managing Partner at CVC, commented: “We are excited to announce this deal, which marks the beginning of a new chapter in India’s most popular sporting event and our team Gujarat Titans. Our participation in Indian Cricket started strongly, securing the Gujarat franchise, winning the IPL title in our first season and emerging as runners up in our second season. Amit Soni, Partner at CVC, added, “We are delighted to be able to partner with Torrent, one of the most respected business groups in India. We are now very pleased to welcome the Torrent Group and look forward to unlocking new avenues for growth and development for Gujarat Titans and for the IPL in the years to come.”

CVC has a long history of investment in sports since our investments in Moto GP and Formula One, and we are extremely proud of how this investment in Gujarat Titans has developed.

Nick ClarryManaging Partner at CVC

Nick Clarry, Managing Partner at CVC, said, “CVC has a long history of investment in sports since our investments in Moto GP and Formula One, and we are extremely proud of how this investment in Gujarat Titans has developed. We particularly want to thank our fans, our management team, our players and the BCCI. Because of them, Gujarat Titans has become a leading franchise on and off the pitch, and together with the support of our wonderful fans, we expect this to accelerate with our new partners, Torrent.”

Categories: News

Tags:

Organisational change

3I

3i Group plc (“3i”) today announces a change to the leadership of its Infrastructure business.

Scott Moseley, Co-Head of European Infrastructure, has decided to leave 3i and Bernardo Sottomayor, Co-Head, will now assume sole responsibility for leading 3i’s European Infrastructure team.

Simon Borrows, 3i Chief Executive commented:

“I would like to thank Scott for his hard work and achievements and wish him well for the future. I look forward to continuing to work with Bernardo and the rest of the Infrastructure team as we grow our Infrastructure activities.”

 

-Ends-

Download this press release 

 

For further information, contact:

3i Group plc

Kathryn van der Kroft
Media enquiries

Silvia Santoro
Shareholder enquiries

  

Tel: +44 20 7975 3021
Email: kathryn.vanderkroft@3i.com

Tel: +44 20 7975 3258
Email: silvia.santoro@3i.com

Categories: People

OncoHealth Appoints Jon Maack as Chief Executive Officer to Lead Next Phase of Growth

Arsenal Capital Partners

Atlanta, GA — OncoHealth®, the leading platform for managing the cost and complexity of cancer and a portfolio company of Arsenal Capital Partners (“Arsenal”), today announced that Jon Maack will succeed Rick Dean as the company’s Chief Executive Officer.

After seven years of leadership, Rick Dean will transition from CEO to an advisory role and continue to serve on the Board of Directors. Under his leadership, OncoHealth experienced remarkable growth, expanding its customer base and the scope of its offerings. In the past year alone, the company continued its upward trajectory, now serving over 14 million lives across 20 health plan customers.

Jon Maack brings more than two decades of experience in healthcare IT and services, with leadership roles at the Advisory Board Company, Optum, athenahealth and, most recently, as President of Definitive Healthcare. He has a proven track record of helping organizations scale with an extensive background in the core processes of healthcare—from revenue cycle management to physician workflow. As CEO, Mr. Maack is committed to advancing OncoHealth’s mission by leveraging utilization management, virtual cancer support, and clinical consultations to reduce the physical, mental, and financial toll of cancer on patients and their families.

Scott Blanchette, Chairman of OncoHealth and Director of Arsenal stated, “We are excited to welcome Jon Maack as OncoHealth’s new CEO. With over 20 years of experience in scaling healthcare IT and services, Jon is the ideal leader to guide the company into its next chapter of innovation and impact. We also extend our deepest gratitude to Rick Dean for his outstanding leadership and unwavering dedication and look forward to continued collaboration with him as a board member.”

“It has been a tremendous honor to lead OncoHealth over the past seven years,” shared Rick Dean. “I am deeply proud of the team we’ve built and the impact we’ve made in supporting patients and health plans. I have full confidence that Jon will continue to drive the company forward, building upon our strong foundation.”

Jon Maack expressed, “I am honored to join OncoHealth at such a pivotal moment in its growth. Cancer care is a deeply personal and complex journey, and I look forward to working alongside our talented team, valued customers, dedicated clinicians, and the patients we serve to deliver a better experience for those battling this disease.”

About OncoHealth:

OncoHealth is dedicated to helping health plans, employers, oncologists, and patients navigate the physical, mental, and financial complexities of cancer. Focused 100% on oncology, OncoHealth’s market-leading software and services platform delivers the industry’s first integrated oncology management solution to ensure people with cancer are getting the most appropriate treatment and support. Powered the nation’s first oncology focused 50-state virtual medical group, OncoHealth combines industry leading oncology management with services including 24/7 oncology nursing, mental health, nutrition, and resource navigation to drive impact for our customers and positive outcomes for our patients. To learn more, visit www.oncohealth.us.

Categories: People

Kevel Announces Acquisition of Nexta to Strengthen Its Retail Media Solution and Drive Revenue Growth for Retail Brands

Fulcrum

News release by Kevel

Kevel, the leading provider of API-based retail media ad serving technology, has announced the acquisition of Nexta, an automated advertising self-serve platform. The acquisition illustrates Kevel’s commitment to redefining the retail media landscape with an all-encompassing solution to arm retailers with the right tools to manage multi-channel ad investment, optimize performance and unlock revenue opportunities.

Kevel empowers retailers to build state-of-the-art retail media platforms in house, enabling them to reclaim control and compete within the competitive retail space on a more level playing field. Nexta’s AI-driven ad manager simplifies the advertising experience and enhances efficiency with booking-optimized self-service for retailers, marketplaces and publishers. By integrating Nexta’s powerful technology into The Retail Media CloudTM, Kevel now offers a full-stack solution for high-performing retail media networks, optimizing operations, improving ad personalization, and enabling seamless efficiency with unmatched customization.

“This acquisition reinforces Kevel’s commitment to transforming the retail media landscape by encouraging retailers to launch custom retail media programs that drive marketplace revenue,” said James Avery, CEO, Kevel. “Nexta is an industry leader in AI-driven omni-channel advertising who share our ethos to take back the internet, make advertising accessible for everyone, and support advertisers of all shapes and sizes on a level playing field. We’re extremely excited to bring the team into the Kevel fold, as we continue to advance the industry and keep pace with demand by offering an all-encompassing retail media solution for our customers.”

Kevel specializes in on-site and API-driven ad-serving technology, delivering robust solutions tailored for seamless integration, while Nexta excels in off-site capabilities with a user interface specifically designed to streamline workflows for operations teams. The combined solution brings on-site and off-site retail media under one roof, offering retailers the choice to either use best in breed user interfaces (UIs) for their customers or teams, or to build their own version, tailored to their needs, using APIs.

As Martin Jensen, Founder and Chairman of the Board at Nexta, says, “This merger is more than just a strategic move — it’s a match made in heaven. Kevel brings global market reach, a shared culture of innovation, and a strong, complementary product offering to the table. Together, we’re not just growing, we’re building something extraordinary. By combining forces, Nexta and Kevel are uniquely positioned to create a game-changing solution in the retail media space.”

The global retail media market is growing at unprecedented pace, with investment predicted to increase to nearly $170bn in 2025, according to WARC’s latest forecast. Retailers are increasingly transitioning to media owners and publishers, seeing the potential to unlock new revenue opportunities while also realizing the unique opportunity to leverage robust first-party data and closed-loop attribution, enabling them to engage with customers in a way that hasn’t traditionally been possible.

“At Nexta, our focus has been solely on simplifying and improving the ad experience for retailers, marketplaces and publishers through intelligent self-serve automation and AI-driven insights,” said Jesper Urban, CEO at Nexta. “Our unwavering commitment to making advertising accessible, measurable, and scalable to all advertisers is synonymous with Kevel’s vision and we’re extremely excited to marry our tech with Kevel’s market-leading retail media solution to transform and drive the retail media space forward.”

Puja Rios, COO at Kevel commented, “We work with global retailers and therefore know how important it is for them to have an API-led solution that puts them in full control, with dedicated UIs for their own teams as well as their advertisers, and the ability to execute on-site, off-site and even in-store ad formats all within a single platform. We’re looking forward to extending this to our current customers, as well as retailers considering upgrading their technology.”

Under the terms of the agreement, Kevel will integrate all Nexta product offerings into its existing retail media solution to create a unified, fully customizable, data-driven, automated platform, ensuring retailers can continue to meet the growing demand for high-performing retail media networks. For more information about the acquisition, please visit Kevel.com.

 

About Kevel

Kevel is transforming the retail media space with its cutting-edge, AI-driven ad tech infrastructure APIs that power the Retail Media Cloud™. This groundbreaking solution combines the power of AI insights with API-based technology, allowing multi-brand retailers to build dynamic, customizable ad platforms while maintaining full control of their first-party data. With Kevel, retailers can deliver personalized shopper experiences, optimize ad targeting, and unlock predictive insights to stay ahead in an ever-evolving market.

 

Kevel’s mission is rooted in the belief that every digital retailer should have the tools to create their own tailored ad platform, comparable to industry leaders like Amazon. Harnessing the power of AI for data-driven decision-making, Kevel has helped leading brands such as Chewy, The Home Depot, Edmunds, Lyft, Delivery Hero, Sonae, Slickdeals, and others launch impactful retail media networks—fostering innovation and unlocking new revenue opportunities.Learn more about how Kevel is transforming retail media at www.kevel.com.

Categories: News